Plasmapheresis as therapy to resolve vascular rejection in heart transplantation with severe heart failure: a report of one case
M. Catalán (a), R. Llorens (c), J. J. Legarra (a), I. Segura (b), A. Sarralde (a) and G. Rabago (a)
(a) Cardiovascular Surgery, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra, Pamplona Spain
(b) Cardiology, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra, Pamplona Spain
(c) Hospiten, Santa Cruz de Tenerife, Spain
Magazine: Transplantation Proceedings
Date: Feb 1, 1998Cardiac Surgery [SP]
The predominant causes of late graft loss after orthotopic cardiac transplantation are graft rejection, coronary artery disease, and infection.
The histopathological dianosis of acute rejection of cardiac allograft is based on cellular phenomena such as lymphocytic infultration with myocyte damage. The symptoms may be very different depending on the rejection grading scale. Usually, this form of rejection is resolved with stabdard antirejection therapy: steroid pulse therapy, increasing doses of Cyclosporine A or in the case of therapy-resistance rejection, with monoclonal antibodies.
CITATION Transplant Proc. 1998 Feb;30(1):176-9
you maybe interested
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.